Risk of Potential Glucocorticoid-Related Adverse Events in Patients with Giant Cell Arteritis: Results from a USA-Based Electronic Health Records Database

ConclusionsIn patients with GCA, potential GC-related AEs increased with higher daily oral GC doses. This highlights the need for effective therapies that reduce GC exposure and toxicity.FundingGenentech, Inc.

Source: Rheumatology and Therapy - October 25, 2019 Category: Rheumatology Source Type: research